查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2128624

傷口縫合市場規模、佔有率、成長、全球產業分析、區域趨勢及2026年至2034年預測。

Wound Closure Market Size, Share, Growth and Global Industry Analysis, Regional Insights and Forecast to 2026-2034
出版日期: | 出版商: Fortune Business Insights Pvt. Ltd. | 英文 140 Pages | 商品交期: 2-3個工作天內

價格

傷口縫合市場成長要素

全球傷口縫合市場預計2025年將達到151億美元，並從2026年的160.9億美元成長到2034年的283.4億美元，預測期內複合年成長率（CAGR）為7.33%。北美地區在全球傷口閉合市場中佔領先地位，預計到2025年將佔37.80%的市場佔有率，這得益於其先進的醫療基礎設施、不斷成長的手術量以及技術先進的傷口縫合傷口縫合產品的快速主導。

傷口縫合在外科和急診醫學中發揮著至關重要的作用，它能夠加速傷口癒合、降低感染風險並改善患者預後。縫合線、縫合器、止血劑和醫用黏合劑等產品在一般外科、整形外科、循環系統外科、婦科和眼科等領域的應用日益廣泛。慢性病盛行率的上升、人口老化、創傷病例的增加以及微創手術的普及，都對創新傷口縫合解決方案提出了強勁的需求。此外，持續的產品創新和有利的法規核准也為市場的長期擴張提供了支持。

市場趨勢

影響傷口縫合市場的關鍵趨勢之一是，人們越來越傾向於先進的傷口縫合技術而非傳統方法。由於可吸收縫線、抗菌傷口密封劑、電動縫合器和先進的止血劑具有更優異的治療效果、更低的感染風險和更佳的手術效果，醫療專業人員正擴大採用這些產品。

另一個重要趨勢是微創手術的快速普及。由於這類手術切口較小、恢復較快，因此對能夠減少疤痕、最大限度減少出血並縮短住院時間的精準傷口縫合器械的需求顯著成長。製造商也大力投資研發，以推出安全性和有效性更高的新一代產品。

市場促進因素

慢性病盛行率的不斷上升仍然是傷口縫合市場最強勁的促進因素之一。心血管疾病、整形外科疾病、關節炎、糖尿病和肥胖症病例的增加促使全球外科手術量顯著成長。老年人口的成長，以及老年人更容易罹患慢性病，進一步擴大了先進傷口縫合產品的需求。

創傷和事故病例的增加也透過增加急診手術的數量來推動市場成長。此外，技術的不斷進步、感染預防意識的提高以及主要製造商不斷推出新產品，都在加速醫院和手術中心採用先進的傷口縫合解決方案。

市場限制因素

儘管成長前景良好，但先進傷口縫合器材的高成本仍是一大挑戰。電動縫合器、高級縫線和先進止血劑的價格遠高於傳統替代品，限制了它們在開發中國家和低收入國家的普及應用。

此外，一些新興市場不完全的報銷政策限制了病患獲得先進外科手術的機會。因製造缺陷、污染、標籤問題或品質問題導致的產品召回也給製造商帶來挑戰，影響產品可靠性和市場聲譽。

市場區隔

按產品類型分類，縫合線預計將成為全球市場的主要驅動力，到2026年將佔39.45%的市場佔有率。全球外科手術數量的不斷成長、可吸收縫合線技術的進步以及對感染控制產品日益成長的需求，都將持續推動這一細分市場的發展。止血劑預計將因持續的產品創新而實現強勁成長，而隨著電動和數位化手術系統的引入，縫合器將繼續受到市場的青睞。

按應用領域分類，預計到2026年，一般外科手術將佔最大的市場佔有率，達到22.62%，這主要得益於盲腸切除手術、疝氣修補術和腹腔鏡手術數量的增加。循環系統領域預計將實現最快成長，這主要受心血管疾病負擔加重和全球心血管手術數量上升的推動。

按最終用戶分類，預計到 2026 年，醫院和門診手術中心 (ASC) 將成為市場的主要驅動力，佔 69.90% 的市場佔有率，這主要得益於住院人數的增加、先進的醫療設施以及有利的報銷方案。

區域分析

預計北美將繼續保持其作為區域市場的領先地位，2025年市場規模將達到57.1億美元，並預計在2026年達到61億美元。該地區受益於先進的醫療基礎設施、不斷成長的手術量、優厚的醫保報銷政策以及持續的產品創新。由於慢性病高發生率以及先進傷口縫合技術的日益普及，美國持續推動區域市場的需求。

預計到 2025 年，歐洲市場規模將達到 36.1 億美元，到 2026 年將達到 38.5 億美元。這主要得益於慢性病盛行率的上升、手術數量的增加以及政府為促進手術期間的感染預防所做的努力。

預計亞太市場在 2025 年將達到 36.6 億美元，並在 2026 年擴大到 39 億美元。醫療基礎設施的快速發展、老年人口的成長、手術數量的增加以及法規核准的擴大正在推動該地區的強勁成長，尤其是在中國、日本和印度。

預計拉丁美洲市場規模將在 2025 年達到 12.9 億美元，並在 2026 年成長至 13.7 億美元。同時，在醫療設施改善和手術量增加的推動下，中東和非洲市場規模將從 2025 年的 8.3 億美元成長到 2026 年的 8.7 億美元。

目錄

第1章：引言

第2章摘要整理

第3章 市場動態

  • 市場促進因素
  • 市場限制因素
  • 市場機遇
  • 市場趨勢

第4章：主要考慮因素

  • 主要國家/地區主要治療項目數量（2025 年）
  • 新產品發布：按主要公司分類
  • 傷口縫合市場的技術進步
  • 重大工業發展（合併、收購、合作等）

第5章：全球傷口縫合市場分析、洞察與預測（2021-2034年）

  • 市場分析、洞察與預測：按產品類型分類
    • 縫合線
      • 吸收性
      • 不吸收
    • 止血劑
      • 主動止血劑
      • 被動止血劑
      • 複方止血劑
      • 其他
    • 訂書機
      • 電的
      • 手動的
    • 其他
  • 市場分析、洞察與預測：按應用領域分類
    • 整形外科
    • 婦產科
    • 一般外科
    • 眼科
    • 循環系統
    • 其他
  • 市場分析、洞察與預測：按最終用戶分類
    • 醫院/門診手術中心
    • 專科診所
    • 其他
  • 市場分析、洞察與預測：按地區分類
    • 北美洲
    • 歐洲
    • 亞太地區
    • 拉丁美洲
    • 中東和非洲

第6章：北美傷口縫合市場分析、洞察與預測（2021-2034年）

  • 國家
    • 美國
    • 加拿大

第7章：歐洲傷口縫合市場分析、洞察與預測（2021-2034年）

  • 國家
    • 英國
    • 德國
    • 法國
    • 西班牙
    • 義大利
    • 斯堪地那維亞
    • 其他歐洲國家

第8章：亞太地區傷口縫合市場分析、洞察與預測（2021-2034年）

  • 國家
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 東南亞
    • 亞太其他地區

第9章：拉丁美洲傷口縫合市場分析、洞察與預測（2021-2034年）

  • 國家
    • 巴西
    • 墨西哥
    • 其他拉丁美洲

第10章：中東和非洲傷口縫合市場分析、洞察與預測（2021-2034年）

  • 國家
    • GCC
    • 南非
    • 其他中東和非洲

第11章 競爭分析

  • 全球市佔率分析（2025 年）
  • 公司簡介
    • Johnson & Johnson Services, Inc.
    • Baxter
    • Medtronic
    • Artivion, Inc.
    • Stryker
    • 3M
    • CP Medical（Riverpoint Medical）
    • Boston Scientific Corporation
    • Smith+Nephew
    • B. Braun SE
    • MANI, INC.
    • CONMED Corporation
    • Genesis Medtech
    • CooperSurgical Inc.
    • Intuitive Surgical
    • Frankenman International Ltd.
Product Code: FBI102630

Growth Factors of wound closure Market

The global wound closure market was valued at USD 15.10 billion in 2025 and is projected to grow from USD 16.09 billion in 2026 to USD 28.34 billion by 2034, registering a CAGR of 7.33% during the forecast period. North America dominated the global wound closure market with a 37.80% market share in 2025, supported by advanced healthcare infrastructure, increasing surgical procedures, and rapid adoption of technologically advanced wound closure products.

Wound closure plays a critical role in surgical and emergency care by promoting faster healing, minimizing infection risks, and improving patient outcomes. Products such as sutures, staplers, hemostatic agents, and surgical adhesives are increasingly being used across general surgery, orthopedic, cardiovascular, gynecological, and ophthalmic procedures. The growing prevalence of chronic diseases, rising aging population, increasing trauma cases, and the shift toward minimally invasive surgeries are creating strong demand for innovative wound closure solutions. Additionally, continuous product innovation and favorable regulatory approvals are supporting long-term market expansion.

Market Trends

One of the major trends shaping the wound closure market is the growing preference for advanced wound closure technologies over conventional methods. Healthcare professionals are increasingly adopting absorbable sutures, antibacterial wound sealants, powered staplers, and advanced hemostatic agents due to their superior healing performance, lower infection risk, and improved surgical outcomes.

Another important trend is the rapid adoption of minimally invasive surgical procedures. Since these procedures require smaller incisions and faster recovery, they have significantly increased demand for precision wound closure devices that reduce scarring, minimize bleeding, and shorten hospital stays. Manufacturers are also investing heavily in research and development to introduce next-generation products with enhanced safety and efficiency.

Market Drivers

The increasing prevalence of chronic diseases remains one of the strongest drivers for the wound closure market. Rising cases of cardiovascular disorders, orthopedic diseases, arthritis, diabetes, and obesity have led to a significant increase in surgical procedures worldwide. Growing geriatric populations, who are more susceptible to chronic illnesses, are further expanding the demand for advanced wound closure products.

The rising number of trauma and accident cases also supports market growth by increasing emergency surgical interventions. Furthermore, ongoing technological advancements, growing awareness regarding infection prevention, and continuous product launches by leading manufacturers are accelerating the adoption of advanced wound closure solutions across hospitals and surgical centers.

Market Restraints

Despite strong growth prospects, the high cost of advanced wound closure devices remains a major challenge. Powered staplers, premium sutures, and advanced hemostatic agents are significantly more expensive than conventional alternatives, limiting their adoption in developing and low-income countries.

Additionally, inadequate reimbursement policies in several emerging markets reduce patient access to advanced surgical procedures. Product recalls due to manufacturing defects, contamination, labeling issues, or quality concerns also create challenges for manufacturers by affecting product confidence and market reputation.

Market Segmentation

Based on product type, the sutures segment is expected to dominate the global market with a 39.45% market share in 2026. Increasing surgical procedures worldwide, technological improvements in absorbable sutures, and growing preference for infection-resistant products continue to drive this segment. Hemostatic agents are projected to witness strong growth due to rising product innovations, while staplers continue gaining popularity with the introduction of powered and digitally enabled surgical systems.

By application, the general surgery segment is projected to account for the largest market share of 22.62% in 2026, supported by the growing number of appendectomies, hernia repairs, and laparoscopic procedures. The cardiology segment is expected to register the fastest growth owing to the increasing burden of cardiovascular diseases and rising cardiac surgeries globally.

Based on end user, hospitals and ambulatory surgical centers (ASCs) are expected to dominate the market with a 69.90% share in 2026 due to higher patient admissions, advanced healthcare facilities, and favorable reimbursement systems.

Regional Analysis

North America remained the leading regional market with a value of USD 5.71 billion in 2025 and is expected to reach USD 6.10 billion in 2026. The region benefits from advanced healthcare infrastructure, increasing surgical volumes, strong reimbursement policies, and continuous product innovation. The U.S. continues to dominate regional demand due to the high prevalence of chronic diseases and growing adoption of advanced wound closure technologies.

Europe accounted for USD 3.61 billion in 2025 and is projected to reach USD 3.85 billion in 2026, supported by increasing chronic disease prevalence, rising surgical procedures, and government initiatives promoting infection prevention during surgeries.

Asia Pacific generated USD 3.66 billion in 2025 and is expected to grow to USD 3.90 billion in 2026. Rapid healthcare infrastructure development, rising geriatric population, increasing surgical procedures, and expanding regulatory approvals are driving strong regional growth, particularly in China, Japan, and India.

Latin America reached USD 1.29 billion in 2025 and is projected to grow to USD 1.37 billion in 2026, while the Middle East & Africa market increased from USD 0.83 billion in 2025 to USD 0.87 billion in 2026, supported by improving healthcare facilities and growing surgical volumes.

Competitive Landscape

The global wound closure market remains highly competitive with major companies focusing on product innovation, regulatory approvals, acquisitions, and global expansion. Leading companies include Johnson & Johnson Services, Inc., Baxter, Medtronic, Stryker, Solventum, Smith+Nephew, B. Braun SE, Boston Scientific Corporation, Frankenman International Ltd., CooperSurgical Inc., Intuitive Surgical, MANI, Inc., Artivion, Inc., CP Medical (Riverpoint Medical), CONMED Corporation, and Genesis Medtech. Continuous investments in advanced wound closure technologies, powered staplers, absorbable sutures, and hemostatic products are expected to strengthen market competition over the forecast period.

Key Industry Developments

Recent industry developments continue to enhance innovation in wound closure technologies. In March 2024, Intuitive Surgical received FDA clearance for its next-generation da Vinci 5 robotic surgical system. In February 2024, Boston Scientific reported positive clinical results for its OverStitch endoscopic suturing system. Healthium Medtech introduced its TRUMAS absorbable sutures in August 2023, while Artivion and Baxter secured FDA approvals for the PERCLOT Absorbable Hemostatic System in 2023. Earlier, Johnson & Johnson launched the ECHELON 3000 Stapler, strengthening its advanced surgical device portfolio.

Conclusion

The global wound closure market is expected to witness steady expansion through 2034, driven by the increasing burden of chronic diseases, growing surgical procedures, rapid adoption of minimally invasive techniques, and continuous technological innovation in wound management products. While high product costs and occasional recalls remain challenges, ongoing investments in advanced sutures, staplers, hemostatic agents, and regulatory approvals are expected to create significant growth opportunities. As healthcare systems continue emphasizing safer surgical outcomes and faster patient recovery, the wound closure market is well positioned for sustained long-term growth.

Segmentation By Product Type

  • Sutures
    • Absorbable
    • Non-Absorbable
  • Hemostatic Agents
    • Active Hemostats
    • Passive Hemostats
    • Combination Hemostats
    • Others
  • Staplers
    • Powered
    • Manual
  • Others

By Application

  • Orthopedics
  • Gynecology and Obstetrics
  • General Surgery
  • Ophthalmology
  • Cardiology
  • Others

By End-user

  • Hospitals & ASCs
  • Specialty Clinics
  • Others

By Region

  • North America (By Product Type, By Application, By End-user, and By Country)
    • U.S.
    • Canada
  • Europe (By Product Type, By Application, By End-user, and By Country/Sub-Region)
    • Germany
    • U.K.
    • France
    • Italy
    • Spain
    • Scandinavia
    • Rest of Europe
  • Asia Pacific (By Product Type, By Application, By End-user, and By Country/Sub-Region)
    • China
    • Japan
    • India
    • Australia
    • Southeast Asia
    • Rest of Asia Pacific
  • Latin America (By Product Type, By Application, By End-user, and By Country/Sub-Region)
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa (By Product Type, By Application, By End-user, and By Country/Sub-Region)
    • GCC
    • South Africa
    • Rest of Middle East & Africa

Table of Content

1. Introduction

  • 1.1. Research Scope
  • 1.2. Market Segmentation
  • 1.3. Research Methodology
  • 1.4. Definitions and Assumptions

2. Executive Summary

3. Market Dynamics

  • 3.1. Market Drivers
  • 3.2. Market Restraints
  • 3.3. Market Opportunities
  • 3.4. Market Trends

4. Key Insights

  • 4.1. Number of Key Procedures, by Key Countries/Region, 2025
  • 4.2. New Product Launches - by Key Players
  • 4.3. Technological Advancements in Wound Closure Market
  • 4.4. Key Industry Developments - (Mergers, Acquisitions, Partnerships, etc.)

5. Global Wound Closure Market Analysis, Insights and Forecast, 2021-2034

  • 5.1. Market Analysis, Insights and Forecast - By Product Type
    • 5.1.1. Sutures
      • 5.1.1.1. Absorbable
      • 5.1.1.2. Non-absorbable
    • 5.1.2. Hemostatic Agents
      • 5.1.2.1. Active Hemostats
      • 5.1.2.2. Passive Hemostats
      • 5.1.2.3. Combination Hemostats
      • 5.1.2.4. Others
    • 5.1.3. Staplers
      • 5.1.3.1. Powered
      • 5.1.3.2. Manual
    • 5.1.4. Others
  • 5.2. Market Analysis, Insights and Forecast - By Application
    • 5.2.1. Orthopedics
    • 5.2.2. Gynecology and Obstetrics
    • 5.2.3. General Surgery
    • 5.2.4. Ophthalmology
    • 5.2.5. Cardiology
    • 5.2.6. Others
  • 5.3. Market Analysis, Insights and Forecast - By End User
    • 5.3.1. Hospitals & ASCs
    • 5.3.2. Specialty Clinics
    • 5.3.3. Others
  • 5.4. Market Analysis, Insights and Forecast - By Region
    • 5.4.1. North America
    • 5.4.2. Europe
    • 5.4.3. Asia Pacific
    • 5.4.4. Latin America
    • 5.4.5. Middle East & Africa

6. North America Wound Closure Market Analysis, Insights and Forecast, 2021-2034

  • 6.1. Market Analysis, Insights and Forecast - By Product Type
    • 6.1.1. Sutures
      • 6.1.1.1. Absorbable
      • 6.1.1.2. Non-absorbable
    • 6.1.2. Hemostatic Agents
      • 6.1.2.1. Active Hemostats
      • 6.1.2.2. Passive Hemostats
      • 6.1.2.3. Combination Hemostats
      • 6.1.2.4. Others
    • 6.1.3. Staplers
      • 6.1.3.1. Powered
      • 6.1.3.2. Manual
    • 6.1.4. Others
  • 6.2. Market Analysis, Insights and Forecast - By Application
    • 6.2.1. Orthopedics
    • 6.2.2. Gynecology and Obstetrics
    • 6.2.3. General Surgery
    • 6.2.4. Ophthalmology
    • 6.2.5. Cardiology
    • 6.2.6. Others
  • 6.3. Market Analysis, Insights and Forecast - By End User
    • 6.3.1. Hospitals & ASCs
    • 6.3.2. Specialty Clinics
    • 6.3.3. Others
  • 6.4. Market Analysis, Insights and Forecast - By Country
    • 6.4.1. U.S.
    • 6.4.2. Canada

7. Europe Wound Closure Market Analysis, Insights and Forecast, 2021-2034

  • 7.1. Market Analysis, Insights and Forecast - By Product Type
    • 7.1.1. Sutures
      • 7.1.1.1. Absorbable
      • 7.1.1.2. Non-absorbable
    • 7.1.2. Hemostatic Agents
      • 7.1.2.1. Active Hemostats
      • 7.1.2.2. Passive Hemostats
      • 7.1.2.3. Combination Hemostats
      • 7.1.2.4. Others
    • 7.1.3. Staplers
      • 7.1.3.1. Powered
      • 7.1.3.2. Manual
    • 7.1.4. Others
  • 7.2. Market Analysis, Insights and Forecast - By Application
    • 7.2.1. Orthopedics
    • 7.2.2. Gynecology and Obstetrics
    • 7.2.3. General Surgery
    • 7.2.4. Ophthalmology
    • 7.2.5. Cardiology
    • 7.2.6. Others
  • 7.3. Market Analysis, Insights and Forecast - By End User
    • 7.3.1. Hospitals & ASCs
    • 7.3.2. Specialty Clinics
    • 7.3.3. Others
  • 7.4. Market Analysis, Insights and Forecast - By Country/ Sub-Region
    • 7.4.1. U.K.
    • 7.4.2. Germany
    • 7.4.3. France
    • 7.4.4. Spain
    • 7.4.5. Italy
    • 7.4.6. Scandinavia
    • 7.4.7. Rest of Europe

8. Asia Pacific Wound Closure Market Analysis, Insights and Forecast, 2021-2034

  • 8.1. Market Analysis, Insights and Forecast - By Product Type
    • 8.1.1. Sutures
      • 8.1.1.1. Absorbable
      • 8.1.1.2. Non-absorbable
    • 8.1.2. Hemostatic Agents
      • 8.1.2.1. Active Hemostats
      • 8.1.2.2. Passive Hemostats
      • 8.1.2.3. Combination Hemostats
      • 8.1.2.4. Others
    • 8.1.3. Staplers
      • 8.1.3.1. Powered
      • 8.1.3.2. Manual
    • 8.1.4. Others
  • 8.2. Market Analysis, Insights and Forecast - By Application
    • 8.2.1. Orthopedics
    • 8.2.2. Gynecology and Obstetrics
    • 8.2.3. General Surgery
    • 8.2.4. Ophthalmology
    • 8.2.5. Cardiology
    • 8.2.6. Others
  • 8.3. Market Analysis, Insights and Forecast - By End User
    • 8.3.1. Hospitals & ASCs
    • 8.3.2. Specialty Clinics
    • 8.3.3. Others
  • 8.4. Market Analysis, Insights and Forecast - By Country/ Sub-Region
    • 8.4.1. Japan
    • 8.4.2. China
    • 8.4.3. India
    • 8.4.4. Australia
    • 8.4.5. Southeast Asia
    • 8.4.6. Rest of Asia Pacific

9. Latin America Wound Closure Market Analysis, Insights and Forecast, 2021-2034

  • 9.1. Market Analysis, Insights and Forecast - By Product Type
    • 9.1.1. Sutures
      • 9.1.1.1. Absorbable
      • 9.1.1.2. Non-absorbable
    • 9.1.2. Hemostatic Agents
      • 9.1.2.1. Active Hemostats
      • 9.1.2.2. Passive Hemostats
      • 9.1.2.3. Combination Hemostats
      • 9.1.2.4. Others
    • 9.1.3. Staplers
      • 9.1.3.1. Powered
      • 9.1.3.2. Manual
    • 9.1.4. Others
  • 9.2. Market Analysis, Insights and Forecast - By Application
    • 9.2.1. Orthopedics
    • 9.2.2. Gynecology and Obstetrics
    • 9.2.3. General Surgery
    • 9.2.4. Ophthalmology
    • 9.2.5. Cardiology
    • 9.2.6. Others
  • 9.3. Market Analysis, Insights and Forecast - By End User
    • 9.3.1. Hospitals & ASCs
    • 9.3.2. Specialty Clinics
    • 9.3.3. Others
  • 9.4. Market Analysis, Insights and Forecast - By Country/ Sub-Region
    • 9.4.1. Brazil
    • 9.4.2. Mexico
    • 9.4.3. Rest of Latin America

10. Middle East & Africa Wound Closure Market Analysis, Insights and Forecast, 2021-2034

  • 10.1. Market Analysis, Insights and Forecast - By Product Type
    • 10.1.1. Sutures
      • 10.1.1.1. Absorbable
      • 10.1.1.2. Non-absorbable
    • 10.1.2. Hemostatic Agents
      • 10.1.2.1. Active Hemostats
      • 10.1.2.2. Passive Hemostats
      • 10.1.2.3. Combination Hemostats
      • 10.1.2.4. Others
    • 10.1.3. Staplers
      • 10.1.3.1. Powered
      • 10.1.3.2. Manual
    • 10.1.4. Others
  • 10.2. Market Analysis, Insights and Forecast - By Application
    • 10.2.1. Orthopedics
    • 10.2.2. Gynecology and Obstetrics
    • 10.2.3. General Surgery
    • 10.2.4. Ophthalmology
    • 10.2.5. Cardiology
    • 10.2.6. Others
  • 10.3. Market Analysis, Insights and Forecast - By End User
    • 10.3.1. Hospitals & ASCs
    • 10.3.2. Specialty Clinics
    • 10.3.3. Others
  • 10.4. Market Analysis, Insights and Forecast - By Country/ Sub-Region
    • 10.4.1. GCC
    • 10.4.2. South Africa
    • 10.4.3. Rest of Middle East & Africa

11. Competitive Analysis

  • 11.1. Global Market Share Analysis (2025)
  • 11.2. Company Profiles
    • 11.2.1. Johnson & Johnson Services, Inc.
      • 11.2.1.1. Overview
      • 11.2.1.2. Products
      • 11.2.1.3. SWOT Analysis
      • 11.2.1.4. Recent Developments
      • 11.2.1.5. Strategies
      • 11.2.1.6. Financials (Based on Availability)
    • 11.2.2. Baxter
      • 11.2.2.1. Overview
      • 11.2.2.2. Products
      • 11.2.2.3. SWOT Analysis
      • 11.2.2.4. Recent Developments
      • 11.2.2.5. Strategies
      • 11.2.2.6. Financials (Based on Availability)
    • 11.2.3. Medtronic
      • 11.2.3.1. Overview
      • 11.2.3.2. Products
      • 11.2.3.3. SWOT Analysis
      • 11.2.3.4. Recent Developments
      • 11.2.3.5. Strategies
      • 11.2.3.6. Financials (Based on Availability)
    • 11.2.4. Artivion, Inc.
      • 11.2.4.1. Overview
      • 11.2.4.2. Products
      • 11.2.4.3. SWOT Analysis
      • 11.2.4.4. Recent Developments
      • 11.2.4.5. Strategies
      • 11.2.4.6. Financials (Based on Availability)
    • 11.2.5. Stryker
      • 11.2.5.1. Overview
      • 11.2.5.2. Products
      • 11.2.5.3. SWOT Analysis
      • 11.2.5.4. Recent Developments
      • 11.2.5.5. Strategies
      • 11.2.5.6. Financials (Based on Availability)
    • 11.2.6. 3M
      • 11.2.6.1. Overview
      • 11.2.6.2. Products
      • 11.2.6.3. SWOT Analysis
      • 11.2.6.4. Recent Developments
      • 11.2.6.5. Strategies
      • 11.2.6.6. Financials (Based on Availability)
    • 11.2.7. CP Medical (Riverpoint Medical)
      • 11.2.7.1. Overview
      • 11.2.7.2. Products
      • 11.2.7.3. SWOT Analysis
      • 11.2.7.4. Recent Developments
      • 11.2.7.5. Strategies
      • 11.2.7.6. Financials (Based on Availability)
    • 11.2.8. Boston Scientific Corporation
      • 11.2.8.1. Overview
      • 11.2.8.2. Products
      • 11.2.8.3. SWOT Analysis
      • 11.2.8.4. Recent Developments
      • 11.2.8.5. Strategies
      • 11.2.8.6. Financials (Based on Availability)
    • 11.2.9. Smith+Nephew
      • 11.2.9.1. Overview
      • 11.2.9.2. Products
      • 11.2.9.3. SWOT Analysis
      • 11.2.9.4. Recent Developments
      • 11.2.9.5. Strategies
      • 11.2.9.6. Financials (Based on Availability)
    • 11.2.10. B. Braun SE
      • 11.2.10.1. Overview
      • 11.2.10.2. Products
      • 11.2.10.3. SWOT Analysis
      • 11.2.10.4. Recent Developments
      • 11.2.10.5. Strategies
      • 11.2.10.6. Financials (Based on Availability)
    • 11.2.11. MANI, INC.
      • 11.2.11.1. Overview
      • 11.2.11.2. Products
      • 11.2.11.3. SWOT Analysis
      • 11.2.11.4. Recent Developments
      • 11.2.11.5. Strategies
      • 11.2.11.6. Financials (Based on Availability)
    • 11.2.12. CONMED Corporation
      • 11.2.12.1. Overview
      • 11.2.12.2. Products
      • 11.2.12.3. SWOT Analysis
      • 11.2.12.4. Recent Developments
      • 11.2.12.5. Strategies
      • 11.2.12.6. Financials (Based on Availability)
    • 11.2.13. Genesis Medtech
      • 11.2.13.1. Overview
      • 11.2.13.2. Products
      • 11.2.13.3. SWOT Analysis
      • 11.2.13.4. Recent Developments
      • 11.2.13.5. Strategies
      • 11.2.13.6. Financials (Based on Availability)
    • 11.2.14. CooperSurgical Inc.
      • 11.2.14.1. Overview
      • 11.2.14.2. Products
      • 11.2.14.3. SWOT Analysis
      • 11.2.14.4. Recent Developments
      • 11.2.14.5. Strategies
      • 11.2.14.6. Financials (Based on Availability)
    • 11.2.15. Intuitive Surgical
      • 11.2.15.1. Overview
      • 11.2.15.2. Products
      • 11.2.15.3. SWOT Analysis
      • 11.2.15.4. Recent Developments
      • 11.2.15.5. Strategies
      • 11.2.15.6. Financials (Based on Availability)
    • 11.2.16. Frankenman International Ltd.
      • 11.2.16.1. Overview
      • 11.2.16.2. Products
      • 11.2.16.3. SWOT Analysis
      • 11.2.16.4. Recent Developments
      • 11.2.16.5. Strategies
      • 11.2.16.6. Financials (Based on Availability)

List of Tables

  • Table 1: Global Wound Closure Market Revenue (USD billion) Forecast, by Product Type, 2021-2034
  • Table 2: Global Wound Closure Market Revenue (USD billion) Forecast, by Sutures, 2021-2034
  • Table 3: Global Wound Closure Market Revenue (USD billion) Forecast, by Hemostatic Agents, 2021-2034
  • Table 4: Global Wound Closure Market Revenue (USD billion) Forecast, by Staplers, 2021-2034
  • Table 5: Global Wound Closure Market Revenue (USD billion) Forecast, by Application, 2021-2034
  • Table 6: Global Wound Closure Market Revenue (USD billion) Forecast, by End User, 2021-2034
  • Table 7: Global Wound Closure Market Revenue (USD billion) Forecast, by Region, 2021-2034
  • Table 8: North America Wound Closure Market Revenue (USD billion) Forecast, by Product Type, 2021-2034
  • Table 9: North America Wound Closure Market Revenue (USD billion) Forecast, by Sutures, 2021-2034
  • Table 10: North America Wound Closure Market Revenue (USD billion) Forecast, by Hemostatic Agents, 2021-2034
  • Table 11: North America Wound Closure Market Revenue (USD billion) Forecast, by Staplers, 2021-2034
  • Table 12: North America Wound Closure Market Revenue (USD billion) Forecast, by Application, 2021-2034
  • Table 13: North America Wound Closure Market Revenue (USD billion) Forecast, by End User, 2021-2034
  • Table 14: North America Wound Closure Market Revenue (USD billion) Forecast, By Country, 2021-2034
  • Table 15: Europe Wound Closure Market Revenue (USD billion) Forecast, by Product Type, 2021-2034
  • Table 16: Europe Wound Closure Market Revenue (USD billion) Forecast, by Sutures, 2021-2034
  • Table 17: Europe Wound Closure Market Revenue (USD billion) Forecast, by Hemostatic Agents, 2021-2034
  • Table 18: Europe Wound Closure Market Revenue (USD billion) Forecast, by Staplers, 2021-2034
  • Table 19: Europe Wound Closure Market Revenue (USD billion) Forecast, by Application, 2021-2034
  • Table 20: Europe Wound Closure Market Revenue (USD billion) Forecast, by End User, 2021-2034
  • Table 21: Europe Wound Closure Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2021-2034
  • Table 22: Asia Pacific Wound Closure Market Revenue (USD billion) Forecast, by Product Type, 2021-2034
  • Table 23: Asia Pacific Wound Closure Market Revenue (USD billion) Forecast, by Sutures, 2021-2034
  • Table 24: Asia Pacific Wound Closure Market Revenue (USD billion) Forecast, by Hemostatic Agents, 2021-2034
  • Table 25: Asia Pacific Wound Closure Market Revenue (USD billion) Forecast, by Staplers, 2021-2034
  • Table 26: Asia Pacific Wound Closure Market Revenue (USD billion) Forecast, by Application, 2021-2034
  • Table 27: Asia Pacific Wound Closure Market Revenue (USD billion) Forecast, by End User, 2021-2034
  • Table 28: Asia Pacific Wound Closure Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2021-2034
  • Table 29: Latin America Wound Closure Market Revenue (USD billion) Forecast, by Product Type, 2021-2034
  • Table 30: Latin America Wound Closure Market Revenue (USD billion) Forecast, by Sutures, 2021-2034
  • Table 31: Latin America Wound Closure Market Revenue (USD billion) Forecast, by Hemostatic Agents, 2021-2034
  • Table 32: Latin America Wound Closure Market Revenue (USD billion) Forecast, by Staplers, 2021-2034
  • Table 33: Latin America Wound Closure Market Revenue (USD billion) Forecast, by Application, 2021-2034
  • Table 34: Latin America Wound Closure Market Revenue (USD billion) Forecast, by End User, 2021-2034
  • Table 35: Latin America Wound Closure Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2021-2034
  • Table 36: Middle East & Africa Wound Closure Market Revenue (USD billion) Forecast, by Product Type, 2021-2034
  • Table 37: Middle East & Africa Wound Closure Market Revenue (USD billion) Forecast, by Sutures, 2021-2034
  • Table 38: Middle East & Africa Wound Closure Market Revenue (USD billion) Forecast, by Hemostatic Agents, 2021-2034
  • Table 39: Middle East & Africa Wound Closure Market Revenue (USD billion) Forecast, by Staplers, 2021-2034
  • Table 40: Middle East & Africa Wound Closure Market Revenue (USD billion) Forecast, by Application, 2021-2034
  • Table 41: Middle East & Africa Wound Closure Market Revenue (USD billion) Forecast, by End User, 2021-2034
  • Table 42: Middle East & Africa Wound Closure Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2021-2034

List of Figures

  • Figure 1: Global Wound Closure Market Revenue Breakdown (USD billion, %) by Region, 2025 & 2034
  • Figure 2: Global Wound Closure Market Value Share (%), by Product Type, 2025 & 2034
  • Figure 3: Global Wound Closure Market Value Share (%), by Application, 2025 & 2034
  • Figure 4: Global Wound Closure Market Value Share (%), by End User, 2025 & 2034
  • Figure 5: Global Wound Closure Market Value Share (%), by Region, 2025 & 2034
  • Figure 6: North America Wound Closure Market Value (USD billion), by Product Type, 2025 & 2034
  • Figure 7: North America Wound Closure Market Value Share (%), by Product Type, 2025
  • Figure 8: North America Wound Closure Market Value (USD billion), by Application, 2025 & 2034
  • Figure 9: North America Wound Closure Market Value Share (%), by Application, 2025
  • Figure 10: North America Wound Closure Market Value (USD billion), by End User, 2025 & 2034
  • Figure 11: North America Wound Closure Market Value Share (%), by End User, 2025
  • Figure 12: North America Wound Closure Market Value (USD billion), By Country, 2025 & 2034
  • Figure 13: North America Wound Closure Market Value Share (%), By Country, 2025
  • Figure 14: Europe Wound Closure Market Value (USD billion), by Product Type, 2025 & 2034
  • Figure 15: Europe Wound Closure Market Value Share (%), by Product Type, 2025
  • Figure 16: Europe Wound Closure Market Value (USD billion), by Application, 2025 & 2034
  • Figure 17: Europe Wound Closure Market Value Share (%), by Application, 2025
  • Figure 18: Europe Wound Closure Market Value (USD billion), by End User, 2025 & 2034
  • Figure 19: Europe Wound Closure Market Value Share (%), by End User, 2025
  • Figure 20: Europe Wound Closure Market Value (USD billion), By Country/ Sub-region, 2025 & 2034
  • Figure 21: Europe Wound Closure Market Value Share (%), By Country/ Sub-region, 2025
  • Figure 22: Asia Pacific Wound Closure Market Value (USD billion), by Product Type, 2025 & 2034
  • Figure 23: Asia Pacific Wound Closure Market Value Share (%), by Product Type, 2025
  • Figure 24: Asia Pacific Wound Closure Market Value (USD billion), by Application, 2025 & 2034
  • Figure 25: Asia Pacific Wound Closure Market Value Share (%), by Application, 2025
  • Figure 26: Asia Pacific Wound Closure Market Value (USD billion), by End User, 2025 & 2034
  • Figure 27: Asia Pacific Wound Closure Market Value Share (%), by End User, 2025
  • Figure 28: Asia Pacific Wound Closure Market Value (USD billion), By Country/ Sub-region, 2025 & 2034
  • Figure 29: Asia Pacific Wound Closure Market Value Share (%), By Country/ Sub-region, 2025
  • Figure 30: Latin America Wound Closure Market Value (USD billion), by Product Type, 2025 & 2034
  • Figure 31: Latin America Wound Closure Market Value Share (%), by Product Type, 2025
  • Figure 32: Latin America Wound Closure Market Value (USD billion), by Application, 2025 & 2034
  • Figure 33: Latin America Wound Closure Market Value Share (%), by Application, 2025
  • Figure 34: Latin America Wound Closure Market Value (USD billion), by End User, 2025 & 2034
  • Figure 35: Latin America Wound Closure Market Value Share (%), by End User, 2025
  • Figure 36: Latin America Wound Closure Market Value (USD billion), By Country/ Sub-region, 2025 & 2034
  • Figure 37: Latin America Wound Closure Market Value Share (%), By Country/ Sub-region, 2025
  • Figure 38: Middle East & Africa Wound Closure Market Value (USD billion), by Product Type, 2025 & 2034
  • Figure 39: Middle East & Africa Wound Closure Market Value Share (%), by Product Type, 2025
  • Figure 40: Middle East & Africa Wound Closure Market Value (USD billion), by Application, 2025 & 2034
  • Figure 41: Middle East & Africa Wound Closure Market Value Share (%), by Application, 2025
  • Figure 42: Middle East & Africa Wound Closure Market Value (USD billion), by End User, 2025 & 2034
  • Figure 43: Middle East & Africa Wound Closure Market Value Share (%), by End User, 2025
  • Figure 44: Middle East & Africa Wound Closure Market Value (USD billion), By Country/ Sub-region, 2025 & 2034
  • Figure 45: Middle East & Africa Wound Closure Market Value Share (%), By Country/ Sub-region, 2025
  • Figure 46: Global Wound Closure Market Share (%), By Company, 2025
  • Figure 47: Global Staplers Market Share (%), By Company, 2025